Pharmaceutical companies at AACR 2027
Apr 2–7, 2027 Orlando, FL ~23k attendees Website
25 pharmaceutical companies are at AACR 2027 — 25 with a booth in the exhibit hall. 25 of them have their own page in this guide. As of Sep 27, 2026.
Showing 1–20 of 25 organizations
| Organization | AACR 2027 Attendance |
|---|---|
AbbVie Mettawa, IL | |
Global biopharma whose cancer medicines include targeted drugs for blood cancers and antibody-drug conjugates for solid tumors. | Booth Exhibiting at Booth 2643 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
Amgen Thousand Oaks, CA | |
Large independent biotechnology company developing medicines for serious diseases, including cancer. | Booth Exhibiting at Booth 1934 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
AstraZeneca Cambridge, UK | |
Global biopharma with a large oncology portfolio spanning targeted therapies, antibody-drug conjugates and immunotherapies. | Booth Exhibiting at Booth 1943 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
Bayer Leverkusen, Germany | |
Pharmaceutical and life sciences company whose oncology franchise prioritizes cancer targets and pathways with potential to change how cancer is treated. | Booth Exhibiting at Booth 1043 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
BeOne Medicines San Carlos, CA | |
Global oncology company with blood cancer and solid tumor medicines, including a BTK inhibitor and a PD-1 antibody, and a broad pipeline. | Booth Exhibiting at Booth 2833 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
BioNTech Mainz, Germany | |
Biotechnology company covering research, drug discovery, clinical development, GMP manufacturing and commercialization, focused on oncology and infectious diseases. | Booth Exhibiting at Booth 2157 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
Boehringer Ingelheim Ingelheim am Rhein, Germany | |
Global drugmaker whose oncology pipeline pairs therapies aimed at cancer cells with immuno-oncology approaches, alone and in combination. | Booth Exhibiting at Booth 2381 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
Bristol Myers Squibb Princeton, NJ | |
Global biopharma with cancer immunotherapies, CAR-T cell therapies and blood cancer medicines, alongside immunology, cardiovascular and neuroscience work. | Booth Exhibiting at Booth 1532 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
Daiichi Sankyo Tokyo, Japan | |
Tokyo-based pharmaceutical company with roots in 1899, operating in 32 countries and aiming to become a global healthcare company by 2030. | Booth Exhibiting at Booth 2842 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
Eli Lilly Indianapolis, IN | |
Global pharmaceutical company with medicines in cancer, diabetes, obesity, Alzheimer's disease and immunology. | Booth Exhibiting at Booth 1443 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
EMD Serono Boston, MA | |
US and Canadian healthcare business of Merck KGaA, Darmstadt, Germany, whose oncology research targets hard-to-treat tumor types. | Booth Exhibiting at Booth 1554 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
Exelixis Alameda, CA | |
Oncology company known for cabozantinib, with a pipeline of small-molecule drugs, ADCs and biologics for a widening range of tumor types. | Booth Exhibiting at Booth 2825 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
Genentech South San Francisco, CA | |
Roche Group member that discovers, develops, manufactures and markets medicines for serious and life-threatening conditions. | Booth Exhibiting at Booth 2243 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
Genmab Copenhagen, Denmark | |
International biotechnology company developing antibody medicines for cancer and other serious diseases, with several wholly owned late-stage programs. | Booth Exhibiting at Booth 859 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
Gilead and Kite Foster City, CA | |
Biopharmaceutical company developing medicines for cancer, HIV, viral hepatitis and other life-threatening diseases, exhibiting with Kite, its cell therapy company. | Booth Exhibiting at Booth 2431 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
GSK London, UK | |
Global drugmaker growing its oncology work in blood cancers, gynecologic cancers and other solid tumors through immuno-oncology and tumor-targeting medicines. | Booth Exhibiting at Booth 943 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
Incyte Wilmington, DE | |
Biopharma known for JAK and other targeted cancer medicines, with a pipeline in oncology and in inflammation and autoimmunity, mostly discovered in-house. | Booth Exhibiting at Booth 1143 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
Johnson & Johnson New Brunswick, NJ | |
Healthcare company spanning Innovative Medicine and MedTech; its oncology portfolio includes cell therapy, bispecific antibodies and targeted drugs for myeloma, lung and prostate cancer. | Booth Exhibiting at Booth 2443 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
Merck Rahway, NJ | |
Drugmaker behind Keytruda, running one of the industry's largest oncology development programs across more than 30 tumor types; known as MSD abroad. | Booth Exhibiting at Booth 1929 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
Novartis Basel, Switzerland | |
Swiss medicines company whose oncology portfolio spans targeted therapies such as Kisqali, radioligand therapies and CAR-T cell therapy. | Booth Exhibiting at Booth 650 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
Instantly find 20 buyers from pharmaceutical companies
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse AACR 2027 by
Organization type
Focus
- Genomics and sequencing 82
- Imaging, spatial biology and pathology 59
- Drug discovery and screening 58
- Antibodies and recombinant proteins 52
- Tumor models and cell culture 45
- Immuno-oncology 36
- AI and data 28
- Single-cell analysis and flow cytometry 26
- Liquid biopsy 26
- Targeted therapy 21
- Clinical trials 21
- Proteomics and protein analysis 20
- Cell and gene therapy 19
- Antibody-drug conjugates 18
- Biospecimens and biobanking 17
Exhibit hall
Everyone
Not affiliated with the American Association for Cancer Research. Organization details are derived from AACR’s published exhibitor list. Submit a correction